News and Announcements
Visuo selected as one of 36 start-ups to pitch as part of StartCon’s Pitch for $1 Million competition
- Published December 03, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
StartCon 2019
Our team showcased Visuo at StartCon (Australia’s premier start-up conference) for two days in November, which was a great opportunity to see the positive reactions and feedback on Visuo.
Additionally, Visuo was selected as one of 36 start-ups to pitch as part of StartCon’s Pitch for $1 Million competition. Although Visuo didn’t get selected as one of the regional finalists, it was still a great opportunity to get Visuo’s message out there. We also received a lot of positive comments from attendees after our pitch, which really helps to confirm that we’re doing something special with Visuo.
About Visuo
At Visuo, we aim to make it quick, easy and affordable for businesses to create engaging marketing videos in minutes. With our proprietary AI-powered Intelligent Video Creation Platform, our customers can create social-media ready marketing videos in literally a matter of minutes with no video skills or knowledge whatsoever.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
